Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,447 INR | -1.32% | -2.64% | +16.12% |
05-31 | Cipla's Global Chief Technology Officer Retires | MT |
05-30 | India's pharma export sales to grow faster this year, trade body says | RE |
Sales 2024 | 258B 3.09B 4.21B | Sales 2025 * | 280B 3.36B 4.57B | Capitalization | 1,169B 14.01B 19.09B |
---|---|---|---|---|---|
Net income 2024 | 41.22B 494M 673M | Net income 2025 * | 46.64B 559M 762M | EV / Sales 2024 | 4.69 x |
Net cash position 2024 * | 55.83B 669M 912M | Net cash position 2025 * | 57.4B 688M 938M | EV / Sales 2025 * | 3.97 x |
P/E ratio 2024 |
29.3
x | P/E ratio 2025 * |
25.1
x | Employees | 32,323 |
Yield 2024 * |
0.58% | Yield 2025 * |
0.68% | Free-Float | 67.03% |
Latest transcript on Cipla Limited
1 day | -1.32% | ||
1 week | -2.64% | ||
1 month | +3.37% | ||
3 months | -1.61% | ||
6 months | +20.03% | ||
Current year | +16.12% |
Managers | Title | Age | Since |
---|---|---|---|
Umang Vohra
CEO | Chief Executive Officer | 52 | 15-09-30 |
Ashish Adukia
DFI | Director of Finance/CFO | - | 22-08-15 |
Chief Tech/Sci/R&D Officer | - | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ashok K. Sinha
BRD | Director/Board Member | 72 | 13-07-15 |
Chairman | 87 | 72-07-20 | |
Director/Board Member | 83 | 77-08-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.99% | 6 M€ | +6.07% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1,447 | -1.32% | 3,270,743 |
24-05-30 | 1,467 | -1.80% | 1,732,140 |
24-05-29 | 1,494 | +0.95% | 1,607,691 |
24-05-28 | 1,479 | +0.05% | 784,496 |
24-05-27 | 1,479 | -0.52% | 1,393,334 |
Delayed Quote NSE India S.E., May 31, 2024 at 07:43 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.12% | 14B | |
+15.91% | 41.97B | |
+22.40% | 22.34B | |
+18.48% | 15.25B | |
+45.12% | 12.06B | |
-9.58% | 6.8B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.18% | 5.49B | |
+4.00% | 4.62B |
- Stock Market
- Equities
- CIPLA Stock